IndraLab

Statements



eidos
"A recent study suggested that hydroxychloroquine could significantly reduce the viral load [ 7 ] , but it was conducted in outpatients and a recent trial [ 10 ] performed in the ICU failed to demonstrate any benefit of lopinavir / ritonavir on clinical outcomes and viral load reduction ."

eidos
"In a small study , hydroxychloroquine significantly decreased viral load in COVID-19 patients and the addition of azithromycin further enhanced the reduction in viral load ."

eidos
"[ 10 ] In addition , hydroxychloroquine has been shown to significantly reduce viral load in nasopharyngeal swabs in 20 French patients with COVID-19 ."

eidos
"A nonrandomized 20 patient study showed that HCQ reduced the viral load , but it failed to correlate results with clinical outcomes , providing the basis for many centers ' adoption of this experimental therapy [ 20 ] ."

eidos
"A Phase 2 multi-center open-labeled randomized clinical trial is being conducted in Korea on 150 participants which aim at investigating whether hydroxychloroquine reduces the viral load from the respiratory specimen in patients ."
| PMC

eidos
"[ 3435 ] A study by Gautret et al. showed that HCQ reduced the viral load significantly in SARS-CoV-2 infections ."

eidos
"A Phase 2 multi-center open-labeled randomized clinical trial is being conducted in Korea on 150 participants which aim at investigating whether hydroxychloroquine reduces the viral load from the respiratory specimen in patients ."
| DOI

eidos
"It was also reported that the addition of azithromycin , along with hydroxychloroquine , more effectively reduced the viral load when administered patients [ 133 ] ."

eidos
"259 Hydroxychloroquine and azithromycin reportedly decrease viral load in COVID-19 260 270 results may have some biases ."
| PMC

eidos
"Reduction of viral load by HCQ ."

eidos
"47 These studies , including to date the largest RECOVERY trial , show that at the doses used , CQ or HCQ ( with or without AZM ) is not effective in reduction of viral load , post-exposure prophylaxis , improving survival or reducing the need for respiratory support in hospitalized patients ."

eidos
"In summary , while protease inhibitors may decrease viral burden , inhaled nitric oxide may reduce V / Q mismatch , anticytokine therapy may treat cytokine storm or prevent its progression , and immunomodulators like chloroquine / hydroxychloroquine may inhibit viral replication , RRx-001 may serve as an all-in-one therapy , which improves cardiopulmonary function , decreases viral burden and reduces the systemic inflammatory response ."
| PMC

eidos
"A systematic review 11 concluded that it does not produce clinical benefits , indicating that the use of HCQ does not decrease the viral load and increases mortality from all causes among acute hospitalised patients who have been administered this drug ."

eidos
"RDV ( 12.5 muM ) and HCQ ( 10 muM ) 270 reduced viral titre by 100-and 10-fold , respectively ."
| DOI

eidos
"Early trials demonstrated that HCQ + azithromycin could reduce viral load significantly , resulting in significant absorption of pneumonia and reduced recovery time [ 38 , 39 ] ."

eidos
"7 Recent open-labeled , nonrandomized clinical trials showed that HCQ may decrease viral load and may improve outcomes in a small number of patients with COVID-19 ."

eidos
"Hydroxychloroquine reduced viral load in COVID-19 patients and Azithromycin in addition to Hydroxychloroquine reinforced its anti-viral potential and makes it more efficient in eliminating the virus [ 206 ] ."

eidos
"CQ and HCQ may interfere with virus replication at the early stages of infection or increasing endosome-mediated pH at the viral entry / cell fusion , as well as post-translational modification of the glycosylation of cellular receptors of SARS-CoV-2.6 Along with this , Savarino et al suggested that CQ may reduce the level of inflammatory cytokines and could ameliorate acute respiratory distress syndrome.11 Recent preliminary clinical studies suggested that CQ and HCQ may be able to lower the COVID-19 viral load and reduce the duration of viremia ."

eidos
"Results revealed that hydroxychloroquine could significantly reduce the viral load and azithromycin could reinforce its clinical effect , but the main limitation of this clinical trial was its small sample size 42 ."
| PMC

eidos
"40 A pilot observational study from France demonstrated that HCQ reduced viral load in most COVID-19 patients and that its efficacy was enhanced in combination with azithromycin ."
| PMC

eidos
"Other study suggested that Azithromycin plus Hydroxychloroquine may reduce viral load , nonetheless , the clinical response associated with this approach was not evaluated and remains to be defined [ 16 ] ."

eidos
"According to a very recently published clinical study from France , hydroxychloroquine can significantly reduce viral load in COVID-19 patients , and azithromycin can further enhance this effect [ 22 ] ."
| PMC

eidos
"It has been reported that HCQ alone or in combination with azithromycin reduces viral load and accelerates the recovery of outpatients with mild symptoms of COVID-19 , but no effect on mortality could be observed [ 9 ] ."

eidos
"Further , an open-label non-randomized clinical trial reported that HCQ caused a decline in the viral load in COVID-19 patients ."

eidos
"HCQ prevents the translocation of gp91phox to the membrane and thereby inhibits the activation of NADPH oxidase to reduce oxidative stress and inflammation Fig. 2 : Reduction of viral load by HCQ ."

eidos
"In a small study , hydroxychloroquine significantly decreased the viral load in COVID-19 patients and the addition of azithromycin further enhanced the reduction in viral load [ 10 ] ."

eidos
"French studies suggested that HCQ , mainly when used with azithromycin , could reduce the viral load and improve the outcome of patients infected with SARS-CoV-2 ."

eidos
"In addition , a recent study in SARS-CoV-2-infected cynomolgus macaques showed that HCQ alone or in combination with azithromycin did not result in a significant decrease in viral loads , both in a therapeutic and in a prophylactic setting ( 13 ) ."

eidos
"They concluded that hydroxychloroquine ( 500 mg / day ) and AZ ( 250 mg / day for 5 days ) successfully reduced the viral load ."
| PMC

eidos
"Though , HCQ was reported to promote viral load reduction / disappearance in COVID-19 patients and the effect was reinforced by azithromycin , it is limited by the sample size ( Gautret , et al ., 2020a ) ."

eidos
"reported that HCQ could lead to viral load reduction within six days , especially when combined with azithromycin ."

eidos
"In early clinical studies , chloroquine and hydroxychloroquine were suggested to reduce viral load and improve clinical outcomes in individuals with COVID-19 Gautret et al ., 2020 ) with an even better effect when combined with azithromycin ( Gautret et al ., 2020 ) ."

eidos
"Initially , hydroxychloroquine and azithromycin have been repurposed to reduce viral load in COVID-19 patients [ 4 ] , but these drugs were shown less effective subsequently ."

eidos
"Therefore , HCQ is promising to reduce viral load in COVID-19 patients that is further strengthened by addition of AZ ( Gautret et al ., 2020 ) ."

eidos
"In France , a clinical trial showed that HCQ significantly reduced viral load in patients infected with SARS-CoV-2 , especially when co-administered with azithromycin ( Gautret et al ., 2020a ) , which was supported by the conclusion of another study ( Gautret et al ., 2020b ) ."

eidos
"In early clinical studies , chloroquine and hydroxychloroquine were suggested to reduce viral load and improve clinical outcomes in individuals with COVID-19 ( Gao et al ., 2020 ; Gautret et al ., 2020 ) with an even better effect when combined with azithromycin ( Gautret et al ., 2020 ) ."

eidos
"In the inflammatory cohort , where QTc prolongation was common , CRP reduction was associated with a decrease in IL-6 level and significant QTc shortening Overall evaluation of the available evidence ( Table 1 ) shows that at the doses used , CQ or HCQ ( with or without AZM ) is not effective in reduction of viral load , post-exposure prophylaxis , improving survival or reducing the need for respiratory support in hospitalized patients ."

eidos
"Overall evaluation of the available evidence ( Table 1 ) shows that at the doses used , CQ or HCQ ( with or without AZM ) is not effective in reduction of viral load , post-exposure prophylaxis , improving survival or reducing the need for respiratory support in hospitalized patients ."

eidos
"A study from France reported that hydroxychloroquine significantly reduces the viral load in patients with COVID-19 , and demonstrates synergistic interactions with azithromycin [ 9 ] ."

eidos
"It is estimated that the virus binds ACE2 at acidic pH since hydroxychloroquine reduces the viral load by making pH elevation ."
| PMC

eidos
"In clinical trials , a small open-label and nonrandomized study in France showed hydroxychloroquine could significantly reduce the viral load , and the effects could be enhanced with azithromycin [ 104 ] ."

eidos
"The investigators concluded that HCQ , in conjunction with azithromycin , effectively reduces viral load in COVID-19 ."

eidos
"RDV ( 12.5 muM ) and HCQ ( 10 muM ) reduced viral titre by 100 - and 10-fold , respectively ."

eidos
"A recent study evaluating the in vivo effect of HCQ in Syrian hamster model of COVID-19 reported that HCQ did not reduce viral loads or affect viral transmission even when given at a high dose of 50 mg / kg / day ( Kaptein et al ., 2020 ) ."

eidos
"40 A pilot observational study from France demonstrated that HCQ reduced viral load in most COVID-19 patients and that its efficacy was enhanced in combination with azithromycin.41 HCQ could be administered early in the COVID-19 course to prevent the spread of the infection or in the late stages during the cytokine storm ."
| PMC

eidos
"An open-label non-randomized clinical trial by Gauret et al. showed that HCQ reduces viral load in most COVID-19 patients and that its efficacy is enhanced in combination with azithromycin [ 11 ] ."

eidos
"A non-randomized twenty patient study showed that hydroxychloroquine reduced viral load , but failed to correlate results with clinical outcomes , provided the basis for many centers ' adoption of this experimental therapy [ 19 ] ."
| DOI